Monopar Therapeutics Inc. (MNPR) Ownership

$0.00

$0 (0%)
Last update: 07:00 PM EST
Day's range
$53.94
Day's range
$58.4

Monopar Therapeutics Inc Major Shareholders & Ownership History

Major Shareholder Name Reporting Date Shares Held Market Value Change in Shares Ownership
JANUS HENDERSON GROUP PLC 05/18/2026 1.32 M $72.06 M   0.00% 19.69%
RA CAPITAL MANAGEMENT, L.P. 05/15/2026 667.21 K $36.56 M   0.00% 9.97%
SATURN V CAPITAL MANAGEMENT LLC 05/15/2026 345.63 K $18.94 M   6.12% 5.16%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 05/15/2026 323.75 K $17.74 M   89.82% 4.84%
BLACKROCK, INC. 05/13/2026 316.57 K $17.34 M   24.21% 4.73%
ADAGE CAPITAL PARTNERS GP, L.L.C. 05/15/2026 309.20 K $16.94 M   -51.65% 4.62%
SIREN, L.L.C. 05/14/2026 270.12 K $14.80 M   27.24% 4.04%
ADAR1 CAPITAL MANAGEMENT, LLC 05/18/2026 264.28 K $14.48 M   12.98% 3.95%
POLAR CAPITAL HOLDINGS PLC 05/15/2026 226.53 K $12.41 M   114.21% 3.39%
05/15/2026 218.46 K $11.97 M   100.00% 3.26%
WELLINGTON MANAGEMENT GROUP LLP 05/15/2026 174.34 K $9.55 M   -22.88% 2.61%
SIO CAPITAL MANAGEMENT, LLC 05/14/2026 173.51 K $9.51 M   100.00% 2.59%
BALYASNY ASSET MANAGEMENT L.P. 05/15/2026 136.44 K $7.48 M   327.63% 2.04%
TCG CROSSOVER MANAGEMENT, LLC 05/15/2026 132.10 K $7.24 M   -6.91% 1.97%
ALYESKA INVESTMENT GROUP, L.P. 05/15/2026 100.00 K $5.48 M   150.00% 1.49%
GEODE CAPITAL MANAGEMENT, LLC 05/15/2026 99.92 K $5.48 M   0.92% 1.49%
VIVO CAPITAL, LLC 05/20/2026 90.50 K $4.96 M   0.00% 1.35%
STATE STREET CORP 05/15/2026 88.36 K $4.84 M   5.20% 1.32%
BANK OF NEW YORK MELLON CORP 05/05/2026 78.62 K $4.31 M   21.22% 1.17%
VESTAL POINT CAPITAL, LP 05/15/2026 65.42 K $3.58 M   100.00% 0.98%
WALLEYE CAPITAL LLC 05/13/2026 63.12 K $3.46 M   100.00% 0.94%
BANK OF AMERICA CORP /DE/ 05/18/2026 59.70 K $3.27 M   838.22% 0.89%
CITADEL ADVISORS LLC 05/15/2026 58.44 K $3.20 M   1,051.90% 0.87%
MILLENNIUM MANAGEMENT LLC 05/15/2026 52.95 K $2.90 M   -30.94% 0.79%
PRICE T ROWE ASSOCIATES INC /MD/ 05/15/2026 47.70 K $2.61 M   109.89% 0.71%
05/08/2026 45.99 K $2.52 M   100.00% 0.69%
SILVERARC CAPITAL MANAGEMENT, LLC 05/14/2026 43.49 K $2.38 M   100.00% 0.65%
NEUBERGER BERMAN GROUP LLC 05/14/2026 42.43 K $2.32 M   30.38% 0.63%
UBS GROUP AG 05/05/2026 39.44 K $2.16 M   827.91% 0.59%
GOLDMAN SACHS GROUP INC 05/15/2026 34.71 K $1.90 M   235.01% 0.52%
DRIEHAUS CAPITAL MANAGEMENT LLC 05/15/2026 33.16 K $1.82 M   -1.66% 0.50%
NORTHERN TRUST CORP 05/14/2026 31.86 K $1.75 M   4.51% 0.48%
DEUTSCHE BANK AG\ 05/06/2026 28.82 K $1.58 M   754.49% 0.43%
VANGUARD FIDUCIARY TRUST CO 05/08/2026 28.45 K $1.56 M   100.00% 0.43%
BARCLAYS PLC 05/15/2026 24.94 K $1.37 M   23.17% 0.37%
JUMP FINANCIAL, LLC 05/14/2026 22.81 K $1.25 M   100.00% 0.34%
MORGAN STANLEY 05/15/2026 22.31 K $1.22 M   -17.26% 0.33%
SQUAREPOINT OPS LLC 05/15/2026 21.75 K $1.19 M   106.77% 0.33%
RUSSELL INVESTMENTS GROUP, LTD. 05/08/2026 14.25 K $780.71 K   4,078.59% 0.21%
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 05/15/2026 12.56 K $688.05 K   -12.09% 0.19%
TWO SIGMA INVESTMENTS, LP 05/15/2026 9.77 K $535.02 K   95.73% 0.15%
SEI INVESTMENTS CO 05/13/2026 7.58 K $415.42 K   9.47% 0.11%
WINTON GROUP LTD 05/12/2026 6.83 K $374.16 K   100.00% 0.10%
AMERIPRISE FINANCIAL INC 05/15/2026 6.82 K $373.61 K   100.00% 0.10%
EAM INVESTORS, LLC 05/13/2026 6.23 K $341.07 K   -45.27% 0.09%
CREATIVE PLANNING 05/12/2026 5.99 K $328.03 K   100.00% 0.09%
TD ASSET MANAGEMENT INC 05/11/2026 5.88 K $322.38 K   90.79% 0.09%
GERBER, LLC 04/22/2026 5.60 K $306.88 K   0.00% 0.08%
NUVEEN, LLC 04/30/2026 5.55 K $304.14 K   0.00% 0.08%
RHUMBLINE ADVISERS 05/12/2026 4.95 K $270.98 K   -0.88% 0.07%

Monopar Therapeutics Inc institutional Ownership - FAQ's

During the previous two years, 93 institutional investors and hedge funds held shares of Monopar Therapeutics Inc. The most heavily invested institutionals were:

JANUS HENDERSON GROUP PLC: 1.32 M

RA CAPITAL MANAGEMENT, L.P.: 667,207

Saturn V Capital Management LLC: 345,626

DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C): 323,745

BlackRock, Inc.: 316,567

ADAGE CAPITAL PARTNERS GP, L.L.C.: 309,195

93.18% of Monopar Therapeutics Inc stock is owned by institutional investors.

Institutional investors have bought a total of 6.27 M shares in the last 24 months. This purchase volume represents approximately $363.94 M in transactions.